DOCSLIB.ORG

Camk4 Gene Deletion Induces Hypertension

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Camk4 Gene Deletion Induces Hypertension ORIGINAL RESEARCH CaMK4 Gene Deletion Induces Hypertension Gaetano Santulli, MD; Ersilia Cipolletta, MD; Daniela Sorriento, PhD; Carmine Del Giudice, MS; Antonio Anastasio, MS; Sara Monaco, PhD; Angela Serena Maione, BS; Gianluigi Condorelli, MD, PhD; Annibale Puca, MD, PhD; Bruno Trimarco, MD; Maddalena Illario, MD, PhD; Guido Iaccarino, MD, PhD Background-—The expression of calcium/calmodulin-dependent kinase IV (CaMKIV) was hitherto thought to be confined to the nervous system. However, a recent genome-wide analysis indicated an association between hypertension and a single-nucleotide polymorphism (rs10491334) of the human CaMKIV gene (CaMK4), which suggests a role for this kinase in the regulation of vascular tone. Methods and Results-—To directly assess the role of CaMKIV in hypertension, we characterized the cardiovascular phenotype of CaMK4À/À mice. They displayed a typical hypertensive phenotype, including high blood pressure levels, cardiac hypertrophy, vascular and kidney damage, and reduced tolerance to chronic ischemia and myocardial infarction compared with wild-type littermates. Interestingly, in vitro experiments showed the ability of this kinase to activate endothelial nitric oxide synthase. Eventually, in a population study, we found that the rs10491334 variant associates with a reduction in the expression levels of CaMKIV in lymphocytes from hypertensive patients. Conclusions-—Taken together, our results provide evidence that CaMKIV plays a pivotal role in blood pressure regulation through the control of endothelial nitric oxide synthase activity. ( J Am Heart Assoc. 2012;1:e001081 doi: 10.1161/JAHA.112.001081) Key Words: angiogenesis • arrhythmia • endothelium • hypertension • hypertrophy growing body of evidence bears out the rising interest in single-nucleotide polymorphism (SNP) of the human CaMKIV A the function of calcium/calmodulin-dependent kinases gene (CaMK4). Such a finding suggests that this kinase, the (CaMKs) in cardiovascular pathophysiology. In particular, expression of which once was thought to be confined to the although it is now established that CaMKII is an important nervous tissue,7–10 has a yet unidentified role in the control of player in the regulation of cardiac responses, both in terms of vascular tone. electrophysiology and of cardiac myocyte hypertrophy,1–4 less We therefore hypothesized that CaMKIV could affect is known about the role of other members of the CaMK family, endothelial functions, such as the control of vascular such as CaMKIV, in the cardiovascular system.5 resistance, and that changes in its level of expression or The recent genome-wide analysis of the Framingham Heart activity in endothelial cells (ECs) might alter the fine regulation Study 100K Project6 showed an association between elevated of vascular responses, causing hypertension. To ascertain diastolic blood pressure (BP) and the rs10491334 T/C whether CaMKIV signaling is involved in endothelial dysfunction, a hallmark of the hypertensive state,11–14 we used a murine model of genetic deletion of CaMK4. Finally, a From the Department of Clinical Medicine, Cardiovascular and Immunologic population study was carried out in normotensive and Sciences (G.S., E.C., D.S., C.D.G., A.A., B.T.), Department of Cellular and Molecular Biology and Pathology (S.M., A.S.M., M.I.), “Federico II” University of hypertensive patients to investigate the effects of the CaMK4 Naples, Naples, Italy; Istituto clinico Humanitas IRCCS and Istituto Ricerca rs10491334 SNP in humans. Genetica Biomedica, National Research Council, Rozzano, Italy (G.C.); Multi- medica Research Hospital, Milan, Italy (G.C., A.P., G.I.); Department of Medicine and Surgery, University of Salerno, Salerno, Italy (A.P., G.I.). Correspondence to: Guido Iaccarino, MD, PhD, FESC, Department of Methods Medicine and Surgery, University of Salerno, Via Salvador Allende, 84081 Baronissi (Salerno), Italy. E-mail [email protected] In Vivo Studies Received April 17, 2012; accepted June 21, 2012. ª 2012 The Authors. Published on behalf of the American Heart Association, Animals Inc., by Wiley-Blackwell. This is an Open Access article under the terms of the All animal procedures were performed in accordance with the Creative Commons Attribution Noncommercial License, which permits use, “ distribution and reproduction in any medium, provided the original work is policies and guidelines of the Position of the American Heart 15 properly cited and is not used for commercial purposes. Association on Research Animal Use” and were approved by DOI: 10.1161/JAHA.112.001081 Journal of the American Heart Association 1 CaMK4 and Hypertension Santulli et al ORIGINAL RESEARCH the Ethics Committee of the “Federico II” University. The view.19,20 Intraventricular septal and LV posterior wall thick- European Commission Directive 2010/63/EU was followed. ness were estimated at end diastole. LV fractional shortening We studied male mice with global homozygous deletion of the was calculated as follows: LVFS = [(LVEDD À LVESD)/ CaMK4 gene (CaMK4À/À), backcrossed >12 generations onto LVEDD] 9 100, where LVFS indicates LV fractional shorten- a C57Bl/6J background. The mice were kindly provided by ing; LVEDD, LV end-diastolic diameter; and LVESD, LV Anthony Means (Duke University, Durham, NC).9 Age-matched end-systolic diameter. LV ejection fraction was calculated wild-type littermates (CaMK4+/+) were used as controls. The automatically by the echocardiography system. All measure- animals were housed in a 22°C room with a 12-hour light/ ments were averaged on 10 consecutive cardiac cycles dark cycle and were allowed food and tap water ad libitum. per experiment and were analyzed by one experienced Two groups of mice (CAMK4+/+ and CAMK4À/À) were investigator. subjected to a long-term furosemide treatment (0.35 mg/kg per day) from the age of 3 months until 6 or 18 months. The Electrocardiography drug was added directly to the drinking water. The develop- Electrocardiography (ECG) was performed under isoflurane ment of the typical target-organ damage (vascular, cardiac, (1.5%) anesthesia. Mice were placed on a thermocontrolled 16–18 and kidney damage) was evaluated in 18-month-old plate (37±1°C) and were given 10 minutes to acclimate +/+ mice. Longitudinal survival observation on CAMK4 and before ECG recording. Signal-averaged ECG tracings were À/À CAMK4 mice was performed over a period of 24 months. obtained by subcutaneous placement of 27-gauge steel Genotypes were determined by polymerase chain reaction needle electrodes in each limb, secured with tape. ECG was fi ampli cation of tail DNA. The individual performing all recorded for 60 minutes with the PowerLab Chart 7.1 system experiments was blinded to the mouse genotype until all (ADInstruments, Sydney, Australia) and then was analyzed data were fully analyzed. offline. Invasive Arterial BP Measurement Angiogenic Response After Peripheral Chronic Mice were anesthetized by isoflurane (4%) inhalation and Ischemia fl maintained by mask ventilation (iso urane 1.8%). Direct BP Peripheral chronic ischemia was induced in 6-month-old mice and heart rate measurements were performed with the use of by means of surgical ligation and excision of the right a 1.0F Mikro-Tip catheter (SPR1000, Millar Instruments, common femoral artery. We have published a detailed Houston, TX), which was advanced through the right external description of the procedure.21–23 The angiogenic response carotid artery and placed in the descending aorta. After was assessed on postoperative days 3, 7, 14, and 21 by laser implantation, the catheter was connected to a transducer Doppler (Perimed Instruments, Järfälla, Sweden).22 Further- (Gould Instruments Systems, Cleveland, OH) to record BP and more, 3 weeks after surgery, we performed (1) ultrasound heart rate for 15 minutes. The pressure catheter then was Doppler analysis of the posterior tibial artery with a VeVo770 advanced through the aortic valve into the left ventricle (LV). imaging system equipped with a 20- to 60-MHz scanhead fl fi Subsequent of ine evaluation provided the rst derivative of (VisualSonics, Inc, Toronto, Canada), (2) dyed-microbead the LV pressure curve (maximum and minimum dP/dt). All assay on the gastrocnemius muscle, and (3) histological data were analyzed with dedicated software (PowerLab-Chart analysis of the anterior tibial muscle. 7.1, ADInstruments, Sydney, Australia). Myocardial Infarction Echocardiography Reproducible infarcts of the anterior LV wall were imposed on Transthoracic echocardiography was performed with a small- 6-month-old mice by cryogeny with a 6-mm2 cryoprobe. animal high-resolution imaging system (VeVo770, VisualSon- Briefly, after isofluorane (2%) anesthesia, a thoracotomy was ics, Inc, Toronto, Canada) equipped with a 30-MHz transducer performed through the fourth left intercostal space, the (Real-Time Micro Visualization, RMV-707B). The mice, anes- pericardium was opened, and the heart was exposed. thetized as described previously for BP measurement, were Cryoinfarction was produced by applying the cryoprobe to placed in a shallow left lateral decubitus position, with strict the anterior LV free wall, followed by freezing for 10 seconds. thermoregulation (37±1°C) to optimize physiological condi- The exact position of the probe was set carefully by using the tions and reduce hemodynamic variability. Fur was removed left atrium and pulmonary artery as anatomic landmarks. from the chest by application of a cosmetic cream (Veet, Rinsing with room-temperature saline was performed to allow
Load more

Recommended publications
  • Gene Symbol Gene Description ACVR1B Activin a Receptor, Type IB
    Table S1. Kinase clones included in human kinase cDNA library for yeast two-hybrid screening Gene Symbol Gene Description ACVR1B activin A receptor, type IB ADCK2 aarF domain containing kinase 2 ADCK4 aarF domain containing kinase 4 AGK multiple substrate lipid kinase;MULK AK1 adenylate kinase 1 AK3 adenylate kinase 3 like 1 AK3L1 adenylate kinase 3 ALDH18A1 aldehyde dehydrogenase 18 family, member A1;ALDH18A1 ALK anaplastic lymphoma kinase (Ki-1) ALPK1 alpha-kinase 1 ALPK2 alpha-kinase 2 AMHR2 anti-Mullerian hormone receptor, type II ARAF v-raf murine sarcoma 3611 viral oncogene homolog 1 ARSG arylsulfatase G;ARSG AURKB aurora kinase B AURKC aurora kinase C BCKDK branched chain alpha-ketoacid dehydrogenase kinase BMPR1A bone morphogenetic protein receptor, type IA BMPR2 bone morphogenetic protein receptor, type II (serine/threonine kinase) BRAF v-raf murine sarcoma viral oncogene homolog B1 BRD3 bromodomain containing 3 BRD4 bromodomain containing 4 BTK Bruton agammaglobulinemia tyrosine kinase BUB1 BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) BUB1B BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) C9orf98 chromosome 9 open reading frame 98;C9orf98 CABC1 chaperone, ABC1 activity of bc1 complex like (S. pombe) CALM1 calmodulin 1 (phosphorylase kinase, delta) CALM2 calmodulin 2 (phosphorylase kinase, delta) CALM3 calmodulin 3 (phosphorylase kinase, delta) CAMK1 calcium/calmodulin-dependent protein kinase I CAMK2A calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha CAMK2B calcium/calmodulin-dependent
    [Show full text]
  • Mtor Coordinates Transcriptional Programs and Mitochondrial Metabolism of Activated Treg Subsets to Protect Tissue Homeostasis
    ARTICLE DOI: 10.1038/s41467-018-04392-5 OPEN mTOR coordinates transcriptional programs and mitochondrial metabolism of activated Treg subsets to protect tissue homeostasis Nicole M. Chapman1, Hu Zeng 1, Thanh-Long M. Nguyen1, Yanyan Wang1, Peter Vogel 2, Yogesh Dhungana1, Xiaojing Liu3, Geoffrey Neale 4, Jason W. Locasale 3 & Hongbo Chi1 1234567890():,; Regulatory T (Treg) cells derived from the thymus (tTreg) and periphery (pTreg) have central and distinct functions in immunosuppression, but mechanisms for the generation and acti- vation of Treg subsets in vivo are unclear. Here, we show that mechanistic target of rapamycin (mTOR) unexpectedly supports the homeostasis and functional activation of tTreg and pTreg cells. mTOR signaling is crucial for programming activated Treg-cell function to protect immune tolerance and tissue homeostasis. Treg-specific deletion of mTOR drives sponta- neous effector T-cell activation and inflammation in barrier tissues and is associated with reduction in both thymic-derived effector Treg (eTreg) and pTreg cells. Mechanistically, mTOR functions downstream of antigenic signals to drive IRF4 expression and mitochondrial metabolism, and accordingly, deletion of mitochondrial transcription factor A (Tfam) severely impairs Treg-cell suppressive function and eTreg-cell generation. Collectively, our results show that mTOR coordinates transcriptional and metabolic programs in activated Treg subsets to mediate tissue homeostasis. 1 Department of Immunology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, MS 351, Memphis, TN 38105, USA. 2 Department of Pathology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, MS 250, Memphis, TN 38105, USA. 3 Department of Pharmacology & Cancer Biology, Duke University School of Medicine, Levine Science Research Center C266, Box 3813, Durham, NC 27710, USA.
    [Show full text]
  • Support Info
    Electronic Supplementary Material (ESI) for RSC Advances. This journal is © The Royal Society of Chemistry 2014 Supporting Information Design and synthesis of pyrrole–5-(2,6-dichlorobenzyl)sulfonylindolin-2-ones with C- 3’ side chains as potent Met kinase inhibitors Chia-Wei Liu,a Chun-Liang Lai,a Yu-Hsiang Lin,a Li-Wei Teng,a Sheng-chuan Yang,a Win-Yin Wei,a Shu Fu Lin,a Ju-Ying Yang,a Hung-Jyun Huang,a Ru-Wen Wang,a Chao-Cheng Chiang,a Mei-Hui Lee,a Yu- Chuan Wang,b Shih-Hsien Chuang,a Jia-Ming Chang,a Ying-Shuan E. Lee,a and Jiann-Jyh Huang*a,b aDevelopment Center for Biotechnology, No. 101, Lane 169, Kangning St., Xizhi District, New Taipei City 22180, Taiwan bDepartment of Applied Chemistry, National Chiayi University, No. 300, Syuefu Rd., Chiayi City 60004, Taiwan *Corresponding Author. Tel.: +886 5 271 7959; Fax: +886 5 271 7901. E-mail address: [email protected] (J.-J. Huang) Table of Contents: Page Supporting Figure. Ligplot diagrams of the ATP binding site of Met S2 complexed with compounds 2 and 20. Supporting Table. Kinase profiling data of compound 20. S3 References S10 - S1 - Supporting Figure. Ligplot diagrams1 of the ATP binding site of Met complexed with compounds 2 and 20: (A) Met with 2, and (B) Met with 20. - S2 - Supporting Table. Kinase profiling data of 20. Ambit KinomeScan Kinase Profiling (1.0 μM test concentration): Percentage of Percentage of Ambit Gene Symbol control (%) Ambit Gene Symbol control (%) 20 20 AAK1 68 ARK5 27 ABL1(E255K)-phosphorylated 85 ASK1 100 ABL1(F317I)-nonphosphorylated 78 ASK2 67
    [Show full text]
  • Profiling Data
    Compound Name DiscoveRx Gene Symbol Entrez Gene Percent Compound Symbol Control Concentration (nM) JNK-IN-8 AAK1 AAK1 69 1000 JNK-IN-8 ABL1(E255K)-phosphorylated ABL1 100 1000 JNK-IN-8 ABL1(F317I)-nonphosphorylated ABL1 87 1000 JNK-IN-8 ABL1(F317I)-phosphorylated ABL1 100 1000 JNK-IN-8 ABL1(F317L)-nonphosphorylated ABL1 65 1000 JNK-IN-8 ABL1(F317L)-phosphorylated ABL1 61 1000 JNK-IN-8 ABL1(H396P)-nonphosphorylated ABL1 42 1000 JNK-IN-8 ABL1(H396P)-phosphorylated ABL1 60 1000 JNK-IN-8 ABL1(M351T)-phosphorylated ABL1 81 1000 JNK-IN-8 ABL1(Q252H)-nonphosphorylated ABL1 100 1000 JNK-IN-8 ABL1(Q252H)-phosphorylated ABL1 56 1000 JNK-IN-8 ABL1(T315I)-nonphosphorylated ABL1 100 1000 JNK-IN-8 ABL1(T315I)-phosphorylated ABL1 92 1000 JNK-IN-8 ABL1(Y253F)-phosphorylated ABL1 71 1000 JNK-IN-8 ABL1-nonphosphorylated ABL1 97 1000 JNK-IN-8 ABL1-phosphorylated ABL1 100 1000 JNK-IN-8 ABL2 ABL2 97 1000 JNK-IN-8 ACVR1 ACVR1 100 1000 JNK-IN-8 ACVR1B ACVR1B 88 1000 JNK-IN-8 ACVR2A ACVR2A 100 1000 JNK-IN-8 ACVR2B ACVR2B 100 1000 JNK-IN-8 ACVRL1 ACVRL1 96 1000 JNK-IN-8 ADCK3 CABC1 100 1000 JNK-IN-8 ADCK4 ADCK4 93 1000 JNK-IN-8 AKT1 AKT1 100 1000 JNK-IN-8 AKT2 AKT2 100 1000 JNK-IN-8 AKT3 AKT3 100 1000 JNK-IN-8 ALK ALK 85 1000 JNK-IN-8 AMPK-alpha1 PRKAA1 100 1000 JNK-IN-8 AMPK-alpha2 PRKAA2 84 1000 JNK-IN-8 ANKK1 ANKK1 75 1000 JNK-IN-8 ARK5 NUAK1 100 1000 JNK-IN-8 ASK1 MAP3K5 100 1000 JNK-IN-8 ASK2 MAP3K6 93 1000 JNK-IN-8 AURKA AURKA 100 1000 JNK-IN-8 AURKA AURKA 84 1000 JNK-IN-8 AURKB AURKB 83 1000 JNK-IN-8 AURKB AURKB 96 1000 JNK-IN-8 AURKC AURKC 95 1000 JNK-IN-8
    [Show full text]
  • Camk4 Compromises Podocyte Function in Autoimmune and Nonautoimmune Kidney Disease
    CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease Kayaho Maeda, … , Maria G. Tsokos, George C. Tsokos J Clin Invest. 2018;128(8):3445-3459. https://doi.org/10.1172/JCI99507. Research Article Autoimmunity Nephrology Podocyte malfunction occurs in autoimmune and nonautoimmune kidney disease. Calcium signaling is essential for podocyte injury, but the role of Ca2+/calmodulin–dependent kinase (CaMK) signaling in podocytes has not been fully explored. We report that podocytes from patients with lupus nephritis and focal segmental glomerulosclerosis and lupus- prone and lipopolysaccharide- or adriamycin-treated mice display increased expression of CaMK IV (CaMK4), but not CaMK2. Mechanistically, CaMK4 modulated podocyte motility by altering the expression of the GTPases Rac1 and RhoA and suppressed the expression of nephrin, synaptopodin, and actin fibers in podocytes. In addition, it phosphorylated the scaffold protein 14-3-3β, which resulted in the release and degradation of synaptopodin. Targeted delivery of a CaMK4 inhibitor to podocytes preserved their ultrastructure, averted immune complex deposition and crescent formation, and suppressed proteinuria in lupus-prone mice and proteinuria in mice exposed to lipopolysaccharide-induced podocyte injury by preserving nephrin/synaptopodin expression. In animals exposed to adriamycin, podocyte-specific delivery of a CaMK4 inhibitor prevented and reversed podocyte injury and renal disease. We conclude that CaMK4 is pivotal in immune and nonimmune podocyte injury and that its targeted cell-specific inhibition preserves podocyte structure and function and should have therapeutic value in lupus nephritis and podocytopathies, including focal segmental glomerulosclerosis. Find the latest version: https://jci.me/99507/pdf The Journal of Clinical Investigation RESEARCH ARTICLE CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease Kayaho Maeda,1 Kotaro Otomo,1 Nobuya Yoshida,1 Mones S.
    [Show full text]
  • Supplementary Table 1. in Vitro Side Effect Profiling Study for LDN/OSU-0212320. Neurotransmitter Related Steroids
    Supplementary Table 1. In vitro side effect profiling study for LDN/OSU-0212320. Percent Inhibition Receptor 10 µM Neurotransmitter Related Adenosine, Non-selective 7.29% Adrenergic, Alpha 1, Non-selective 24.98% Adrenergic, Alpha 2, Non-selective 27.18% Adrenergic, Beta, Non-selective -20.94% Dopamine Transporter 8.69% Dopamine, D1 (h) 8.48% Dopamine, D2s (h) 4.06% GABA A, Agonist Site -16.15% GABA A, BDZ, alpha 1 site 12.73% GABA-B 13.60% Glutamate, AMPA Site (Ionotropic) 12.06% Glutamate, Kainate Site (Ionotropic) -1.03% Glutamate, NMDA Agonist Site (Ionotropic) 0.12% Glutamate, NMDA, Glycine (Stry-insens Site) 9.84% (Ionotropic) Glycine, Strychnine-sensitive 0.99% Histamine, H1 -5.54% Histamine, H2 16.54% Histamine, H3 4.80% Melatonin, Non-selective -5.54% Muscarinic, M1 (hr) -1.88% Muscarinic, M2 (h) 0.82% Muscarinic, Non-selective, Central 29.04% Muscarinic, Non-selective, Peripheral 0.29% Nicotinic, Neuronal (-BnTx insensitive) 7.85% Norepinephrine Transporter 2.87% Opioid, Non-selective -0.09% Opioid, Orphanin, ORL1 (h) 11.55% Serotonin Transporter -3.02% Serotonin, Non-selective 26.33% Sigma, Non-Selective 10.19% Steroids Estrogen 11.16% 1 Percent Inhibition Receptor 10 µM Testosterone (cytosolic) (h) 12.50% Ion Channels Calcium Channel, Type L (Dihydropyridine Site) 43.18% Calcium Channel, Type N 4.15% Potassium Channel, ATP-Sensitive -4.05% Potassium Channel, Ca2+ Act., VI 17.80% Potassium Channel, I(Kr) (hERG) (h) -6.44% Sodium, Site 2 -0.39% Second Messengers Nitric Oxide, NOS (Neuronal-Binding) -17.09% Prostaglandins Leukotriene,
    [Show full text]
  • Supplementary Material DNA Methylation in Inflammatory Pathways Modifies the Association Between BMI and Adult-Onset Non- Atopic
    Supplementary Material DNA Methylation in Inflammatory Pathways Modifies the Association between BMI and Adult-Onset Non- Atopic Asthma Ayoung Jeong 1,2, Medea Imboden 1,2, Akram Ghantous 3, Alexei Novoloaca 3, Anne-Elie Carsin 4,5,6, Manolis Kogevinas 4,5,6, Christian Schindler 1,2, Gianfranco Lovison 7, Zdenko Herceg 3, Cyrille Cuenin 3, Roel Vermeulen 8, Deborah Jarvis 9, André F. S. Amaral 9, Florian Kronenberg 10, Paolo Vineis 11,12 and Nicole Probst-Hensch 1,2,* 1 Swiss Tropical and Public Health Institute, 4051 Basel, Switzerland; [email protected] (A.J.); [email protected] (M.I.); [email protected] (C.S.) 2 Department of Public Health, University of Basel, 4001 Basel, Switzerland 3 International Agency for Research on Cancer, 69372 Lyon, France; [email protected] (A.G.); [email protected] (A.N.); [email protected] (Z.H.); [email protected] (C.C.) 4 ISGlobal, Barcelona Institute for Global Health, 08003 Barcelona, Spain; [email protected] (A.-E.C.); [email protected] (M.K.) 5 Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain 6 CIBER Epidemiología y Salud Pública (CIBERESP), 08005 Barcelona, Spain 7 Department of Economics, Business and Statistics, University of Palermo, 90128 Palermo, Italy; [email protected] 8 Environmental Epidemiology Division, Utrecht University, Institute for Risk Assessment Sciences, 3584CM Utrecht, Netherlands; [email protected] 9 Population Health and Occupational Disease, National Heart and Lung Institute, Imperial College, SW3 6LR London, UK; [email protected] (D.J.); [email protected] (A.F.S.A.) 10 Division of Genetic Epidemiology, Medical University of Innsbruck, 6020 Innsbruck, Austria; [email protected] 11 MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, W2 1PG London, UK; [email protected] 12 Italian Institute for Genomic Medicine (IIGM), 10126 Turin, Italy * Correspondence: [email protected]; Tel.: +41-61-284-8378 Int.
    [Show full text]
  • CAMK4 Kinase Enzyme System Application Notepdf
    ADP-Glo™ Kinase Assay Application Notes SER-THR KINASE SERIES: CAMK4 CAMK4 Kinase Assay By Mary Sobol, M.S., Hicham Zegzouti, Ph.D., Jolanta Vidugiriene, Ph.D., and Said A. Goueli, Ph.D., Promega Corporation Scientific Background: CAMK4 is a multifunctional serine/threonine protein kinase and a member of Ca(2+)/calmodulin‐ dependent protein kinase family. CAMK4 is localized in neurons in the hippocampus, amygdala, anterior cingulate cortex, somatosensory cortex, and insular cortex (1). CAMK4 is involved in neural activity‐dependent signaling in the neuronal nucleus and thought to plays an important role in the consolidation/retention of hippocampus‐dependent long‐term memory (2). 1. Sikela, J. M. et al: Chromosomal localization of the human gene for brain Ca(2+)/calmodulin‐dependent protein kinase type IV. Genomics 4: 21‐27, 1989. 2. Kang, H. et al: An important role of neural activity‐ dependent CaMKIV signaling in the consolidation of long‐term memory. Cell 106: 771‐783, 2001. Figure 1. Principle of the ADP‐Glo™ Kinase Assay. The ATP remaining after completion of the kinase reaction is depleted prior to an ADP to ATP ADP-Glo™ Kinase Assay conversion step and quantitation of the newly synthesized ATP using luciferase/luciferin reaction. Description ADP‐Glo™ Kinase Assay is a luminescent kinase assay that measures ADP formed from a kinase reaction; ADP is converted into ATP, which is converted into light by Ultra‐Glo™ Luciferase (Fig. 1). The luminescent signal positively correlates with ADP amount (Fig. 2) and kinase activity (Fig. 3A). The assay is well suited for measuring the effects chemical compounds have on the activity of a broad range of purified kinases—making it ideal for both primary screening as well as kinase selectivity profiling (Fig.
    [Show full text]
  • CAMK4, Active Full-Length Human Recombinant Protein Expressed in Sf9 Cells
    Catalog # Aliquot Size C15-10G -05 5 µg C15-10G -10 10 µg CAMK4, Active Full-length human recombinant protein expressed in Sf9 cells Catalog # C15-10G Lot # U1705-5 Product Description Specific Activity Recombinant full-length human CAMK4 was expressed by baculovirus in Sf9 insect cells using an N-terminal GST 240,000 tag. The gene accession number is NM_001744. 180,000 Gene Aliases 120,000 60,000 CaMK-GR, MGC36771 Activity(cpm) 0 Formulation 0 50 100 150 200 Protein (ng) Recombinant protein stored in 50mM Tris-HCl, pH 7.5, The specific activity of CAMK4 was determined to be 78 nmol 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM /min/mg as per activity assay protocol. DTT, 0.1mM PMSF, 25% glycerol. Purity Storage and Stability Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple The purity was determined to be >90% by densitometry. freeze/thaw cycles. Approx. MW 79kDa. Scientific Background CAMK4 is a multifunctional serine/threonine protein kinase and a member of Ca(2+)/calmodulin-dependent protein kinase family. CAMK4 is localized in neurons in the CAMK4, Active hippocampus, amygdala, anterior cingulate cortex, Full-length human recombinant protein expressed in Sf9 cells somatosensory cortex, and insular cortex (1). CAMK4 is involved in neural activity-dependent signaling in the Catalog # C15-10G neuronal nucleus and thought to plays an important role Specific Activity 78 nmol/min/mg in the consolidation/retention of hippocampus- Specific Lot # U1705-5 dependent long-term memory (2).
    [Show full text]
  • The Calcium/Calmodulin-Dependent Kinases II and IV As Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders
    International Journal of Molecular Sciences Review The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders Kinga Sałaciak 1, Aleksandra Koszałka 1, Elzbieta˙ Zmudzka˙ 2 and Karolina Pytka 1,* 1 Department of Pharmacodynamics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland; [email protected] (K.S.); [email protected] (A.K.) 2 Department of Social Pharmacy, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland; [email protected] * Correspondence: [email protected] Abstract: CaMKII and CaMKIV are calcium/calmodulin-dependent kinases playing a rudimentary role in many regulatory processes in the organism. These kinases attract increasing interest due to their involvement primarily in memory and plasticity and various cellular functions. Although CaMKII and CaMKIV are mostly recognized as the important cogs in a memory machine, little is known about their effect on mood and role in neuropsychiatric diseases etiology. Here, we aimed to review the structure and functions of CaMKII and CaMKIV, as well as how these kinases modulate the animals’ behavior to promote antidepressant-like, anxiolytic-like, and procognitive effects. The review will help in the understanding of the roles of the above kinases in the selected neurodegenerative and neuropsychiatric disorders, and this knowledge can be used in future drug design. Citation: Sałaciak, K.; Koszałka, A.; Zmudzka,˙ E.; Pytka, K. The Keywords: CaMKII; CaMKIV; memory; depression; anxiety; animal studies Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders. Int. J. 1.
    [Show full text]
  • PRODUCT SPECIFICATION Prest Antigen CAMK4 Product Datasheet
    PrEST Antigen CAMK4 Product Datasheet PrEST Antigen PRODUCT SPECIFICATION Product Name PrEST Antigen CAMK4 Product Number APrEST71433 Gene Description calcium/calmodulin-dependent protein kinase IV Alternative Gene CaMK-GR Names Corresponding Anti-CAMK4 (HPA011753) Antibodies Description Recombinant protein fragment of Human CAMK4 Amino Acid Sequence Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence: GNEDMKAIPEGEKIQGDGAQAAVKGAQAELMKVQALEKVKGADINAEEAP KMVPKAVEDGIKVADLELEEGLAEEKLKTVEEAAAPREGQGSSAVGFEVP QQ Fusion Tag N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) Expression Host E. coli Purification IMAC purification Predicted MW 28 kDa including tags Usage Suitable as control in WB and preadsorption assays using indicated corresponding antibodies. Purity >80% by SDS-PAGE and Coomassie blue staining Buffer PBS and 1M Urea, pH 7.4. Unit Size 100 µl Concentration Lot dependent Storage Upon delivery store at -20°C. Avoid repeated freeze/thaw cycles. Notes Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user. Product of Sweden. For research use only. Not intended for pharmaceutical development, diagnostic, therapeutic or any in vivo use. No products from Atlas Antibodies may be resold, modified for resale or used to manufacture commercial products without prior written approval from Atlas Antibodies AB. Warranty: The products supplied by Atlas Antibodies are warranted to meet stated product specifications and to conform to label descriptions when used and stored properly. Unless otherwise stated, this warranty is limited to one year from date of sales for products used, handled and stored according to Atlas Antibodies AB's instructions. Atlas Antibodies AB's sole liability is limited to replacement of the product or refund of the purchase price.
    [Show full text]
  • Inhibition of ERK 1/2 Kinases Prevents Tendon Matrix Breakdown Ulrich Blache1,2,3, Stefania L
    www.nature.com/scientificreports OPEN Inhibition of ERK 1/2 kinases prevents tendon matrix breakdown Ulrich Blache1,2,3, Stefania L. Wunderli1,2,3, Amro A. Hussien1,2, Tino Stauber1,2, Gabriel Flückiger1,2, Maja Bollhalder1,2, Barbara Niederöst1,2, Sandro F. Fucentese1 & Jess G. Snedeker1,2* Tendon extracellular matrix (ECM) mechanical unloading results in tissue degradation and breakdown, with niche-dependent cellular stress directing proteolytic degradation of tendon. Here, we show that the extracellular-signal regulated kinase (ERK) pathway is central in tendon degradation of load-deprived tissue explants. We show that ERK 1/2 are highly phosphorylated in mechanically unloaded tendon fascicles in a vascular niche-dependent manner. Pharmacological inhibition of ERK 1/2 abolishes the induction of ECM catabolic gene expression (MMPs) and fully prevents loss of mechanical properties. Moreover, ERK 1/2 inhibition in unloaded tendon fascicles suppresses features of pathological tissue remodeling such as collagen type 3 matrix switch and the induction of the pro-fbrotic cytokine interleukin 11. This work demonstrates ERK signaling as a central checkpoint to trigger tendon matrix degradation and remodeling using load-deprived tissue explants. Tendon is a musculoskeletal tissue that transmits muscle force to bone. To accomplish its biomechanical function, tendon tissues adopt a specialized extracellular matrix (ECM) structure1. Te load-bearing tendon compart- ment consists of highly aligned collagen-rich fascicles that are interspersed with tendon stromal cells. Tendon is a mechanosensitive tissue whereby physiological mechanical loading is vital for maintaining tendon archi- tecture and homeostasis2. Mechanical unloading of the tissue, for instance following tendon rupture or more localized micro trauma, leads to proteolytic breakdown of the tissue with severe deterioration of both structural and mechanical properties3–5.
    [Show full text]